Aron Feingold

Aron Feingold is an accomplished communications professional with extensive experience in investor relations and corporate communications within the pharmaceutical industry. Currently serving as Vice President of Investor Relations and Corporate Communications at Zentalis Pharmaceuticals since May 2025, Aron previously held a similar role at Geron Corporation, where responsibilities included advising senior leadership and aligning messaging across the organization. Aron built and led corporate communications and investor relations at Sangamo Therapeutics, overseeing multiple strategic initiatives and enhancing corporate positioning. Prior experience includes roles at Pfizer and Medivation, focusing on oncology communications and managing significant corporate transitions. Aron holds a BA in English from Carleton College and has also studied at the University of St Andrews.